Stay Up to Date
Featured News
FDA APPROVES OGSIVEO™ (NIROGACESTAT), AS THE FIRST MEDICAL THERAPY FOR THE TREATMENT OF ADULTS WITH PROGRESSING DESMOID TUMORS.
Filter by:
June 6, 2022
Registration Is Open For The 2022 Virtual DTRF “Together We Will” Weekend!
Read More about Registration Is Open For The 2022 Virtual DTRF “Together We Will” Weekend!
Clinical Trials May 25, 2022
Breaking News: Springworks Therapeutics Announces Topline Results From Phase 3 DeFi Trial
January 28, 2022
DTRF Launches Radiomics Working Group To Improve Tumor Measurement
Read More about DTRF Launches Radiomics Working Group To Improve Tumor Measurement
January 24, 2022
Special Announcement: DTRF Co-Founder Marlene Portnoy Transitions To Board Of Directors
November 19, 2021
DTRF Receives Global Genes Champions Of Hope “Rare Champion In Advocacy (Foundation)” Award
October 26, 2021
Breaking News: DTRF-Funded Research Results In Two Stable Desmoid Tumor Cell Lines
Read More about Breaking News: DTRF-Funded Research Results In Two Stable Desmoid Tumor Cell Lines
